Drug Trial Radar · NCT05305547
A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,093
Actual
Start
Aug 3, 2022
Primary completion
Jan 7, 2024
Study completion May 24, 2024
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19 starting intervention within 3 days of symptom onset.
Conditions
- SARS-CoV-2 Infection
Interventions
S-217622Drug
Administered as a round tablet.
PlaceboDrug
Administered as a round tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Sustained Symptom ResolutionTime frame: Up to Day 29
Locations
196 sites in 17 countries. Site status is shown where the registry gives one.
Lakeview Clinical Research
Guntersville, Alabama
Voyage Medical Services
Tempe, Arizona
Novak Clinical Research
Tucson, Arizona
Hope Clinical Research
Canoga Park, California
Carbon Health
Culver City, California
NICR
Garden Grove, California
Ark Clinical Research (PARENT)
Long Beach, California
UCSD Antiviral Research Center
San Diego, California
University of California San Francisco (PARENT)
San Francisco, California
Clinical Trials Management Services, 223 E. Thousand Oaks Blvd.
Thousand Oaks, California
Lundquist Institute for BMI, UCLA Medical Center
Torrance, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Whitman-Walker Health
Washington D.C., District of Columbia
University of Florida Clinical & Translational Science Institute
Gainesville, Florida
Universal Medical and Research Center
Miami, Florida
CCR Medical Center, Suite 201
Miami, Florida
Miami Clinical Research
Miami, Florida
Vista Health Research, LLC
Miami, Florida
Quantum Clinical Trials, 333 Arthur Godfrey Road, Suite 202, suite 208
Miami Beach, Florida
Quality Research of South Florida
Miami Lakes, Florida
Accel Research Sites Network, Ormond Clinical Research Unit, 77 West Granada Boulevard
Ormond Beach, Florida
Clinical Research Center of Florida, 550 SW 3rd St.,, Suite #305
Pompano Beach, Florida
Invictus Clinical Research Group, LLC
Pompano Beach, Florida
Santos Research Center, CORP
Tampa, Florida
Masters of Clinical Research
Augusta, Georgia
Leavitt Clinical Research
Idaho Falls, Idaho
Research Network America
Berwyn, Illinois
Rush University Infectious Diseases
Chicago, Illinois
Tandem Clinical Research
Marrero, Louisiana
The Johns Hopkins Hospital
Baltimore, Maryland
Infusion Associates
Grand Rapids, Michigan
Revival Research Institute LLC
Troy, Michigan
Las Vegas Medical Research
Las Vegas, Nevada
AB Clinical Trials
Las Vegas, Nevada
Renal Medicine Associates
Albuquerque, New Mexico
Columbia University Irving Medical Center Division of Infectious Diseases
New York, New York
NY Blood Center Project ACHIEVE
New York, New York
University of Rochester Medical Center
Rochester, New York
Lapis Clinical Research - North State
Denver, North Carolina
Burke Primary Care
Morgantown, North Carolina
Showing 40 of 196 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.